WeVote

Bill

Bill

HB 610

Health insurance; coverage for diabetes.

2025 Regular Session Introduced by Cia Price

Virginia bill requiring health insurers to cover diabetes management supplies and treatments to reduce patient costs and improve disease management access.

Left in Appropriations
0
WeVote Research Nonpartisan
Bill Summary · HB 610

Legislative bill overview

HB 610 requires health insurance plans in Virginia to provide coverage for diabetes management supplies and treatments. The bill aims to reduce out-of-pocket costs for insured Virginians diagnosed with diabetes by mandating comprehensive coverage standards across private and potentially state-regulated insurance products.

Why is this important

Diabetes affects approximately 1 million Virginians and costs individuals significant out-of-pocket expenses for insulin, glucose monitors, and related supplies. Mandated coverage could improve medication adherence and preventive care access, potentially reducing costly emergency interventions and long-term complications like kidney disease and vision loss.

Potential points of contention

  • Insurance cost implications: Mandating broader diabetes coverage may increase premiums for all policyholders, with debate over whether costs are justified or should be addressed through other mechanisms
  • Definition and scope ambiguity: Unclear what specific supplies and treatments qualify (e.g., newer continuous glucose monitors vs. basic testing strips, all insulin types), potentially creating implementation disputes
  • Fiscal burden on state: If coverage mandates apply to state employee or Medicaid plans, Virginia could face significant budget impacts, explaining the bill's routing through Appropriations and fiscal review delays

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.